Patents - stay tuned to the technology

Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Chalcogen bonded directly to ring carbon of the piperidine ring

Subclass of:

546 - Organic compounds -- part of the class 532-570 series

546000000 - ORGANIC COMPOUNDS (CLASS 532, SUBCLASS 1)

546000000 - HETEROCYCLIC CARBON COMPOUNDS CONTAINING A HETERO RING HAVING CHALCOGEN (I.E., OXYGEN, SULFUR, SELENIUM, OR TELLURIUM) OR NITROGEN AS THE ONLY RING HETERO ATOMS (Class 540, subclass 1)

546001000 - Hetero ring is six-membered consisting of one nitrogen and five carbons

546184000 - Piperidines

Patent class list (only not empty are listed)

Deeper subclasses:

Class / Patent application numberDescriptionNumber of patent applications / Date published
546242000 Chalcogen bonded directly to ring carbon of the piperidine ring 17
20080221332Hindered Amine salt compounds - The present invention relates water-soluble hindered amine compounds of the general formula (I):09-11-2008
20090264657Stabilization of body-care and household products against degradation by uv radiation using merocyanine derivatives - Described is the use of specific merocyanine derivatives for protecting body-care and household products from photolytic and oxidative degradation. These compounds perform outstanding UV absorber properties.10-22-2009
20100016600N- and O-Substituted 4-[2-(Diphenylmethoxy)-Ethyl]-1-[(Phenyl)Methyl]Piperdine Analogs and Methods of Treating CNS Disorders Therewith - N- and O-substituted 4[2-diaromaticmethoxy and methylamino)alkyl]piperidines exhibit high CNS activity with respect to the dopamine transporter (DAT) and serotonin transporter (SERT). Preferred compounds exhibit highly differential behavior as between the DAT and SERT and between the DAT and the norepinephrine transporter (NET). The compounds have utility in treating CNS disorders, including but not limited to cocaine addiction, depression, and Parkinson's disease.01-21-2010
20100160638NEW METHOD FOR PREPARING ISOFAGOMINE AND ITS DERIVATIVES - A method for preparing isofagomine, its derivatives, intermediates and salts thereof using novel processes to make isofagomine from D-(−)-arabinose and L-(−)-xylose.06-24-2010
20100168434INHIBITION OF POLYMERISATION - The present invention provides methods and compositions for inhibiting polymerisation of ethylenically unsaturated monomers, which involve the use of nitroxide compound of formula (I):07-01-2010
20110166357METHOD FOR PRODUCING N-SUBSTITUTED-TRANS-4-AZIDOPIPERIDINE-3-OL - An N-substituted-trans-4-azidopiperidin-3-ol represented by formula (II-1)07-07-2011
20110213153PROCESSES FOR THE PREPARATION OF PIPERIDINIC DERIVATIVES AND PHARMACEUTIC COMPOSITIONS CONTAINING THE SAME - Production processes for preparing pharmaceutical compositions containing new molecules capable of inhibiting acetylcholinesterase, thus being useful in the treatment of pathologies associated to cholinergic transmission, such as memory related disorders, neurodegenerative disorders such as Alzheimer's Disease, Miastenia Gravis or in the treatment of intoxications induced by chemical agents of central action.09-01-2011
20120172601ZINC CLUSTER - Disclosed is a novel zinc cluster compound represented by general formula (1): Zn07-05-2012
20120323013PROCESSES FOR THE PREPARATION OF PIPERIDINIC DERIVATIVES AND PHARMACEUTIC COMPOSITIONS CONTAINING THE SAME - Production processes for preparing pharmaceutical compositions containing new molecules capable of inhibiting acetylcholinesterase, thus being useful in the treatment of pathologies associated to cholinergic transmission, such as memory related disorders, neurodegenerative disorders such as Alzheimer's Disease, Miastenia Gravis or in the treatment of intoxications induced by chemical agents of central action.12-20-2012
20130053572Novel Cationic Lipids for Oligonucleotide Delivery - The instant invention provides for novel cationic lipids that can be used in combination with other lipid components such as cholesterol and PEG-lipids to form lipid nanoparticles with oligonucleotides. It is an object of the instant invention to provide a cationic lipid scaffold that is susceptible to hydrolytic instability that may translate into reduced liver residence times and reduced hepatocellular toxicity. The present invention employs acetals and ketals to provide a low pH sensitive chemical handle for degradation.02-28-2013
20140303375PROCESS FOR PREPARING A COMPOUND USEFUL FOR PRODUCING AN OPTICALLY ACTIVE DIAZABICYCLOOCTANE COMPOUND - A process for preparing the compound of the following formula (E):10-09-2014
20150336862CATALYTIC HYDROGENATION USING COMPLEXES OF BASE METALS WITH TRIDENTATE LIGANDS - Complexes of cobalt and nickel with tridentate ligand PNHP11-26-2015
201600318173-PIPERIDONE COMPOUNDS AND THEIR USE AS NEUROKININ-1 (NK1) RECEPTOR ANTAGONISTS - The invention relates to 3-piperidone compounds, and in particular, to (2S)-phenyl-3-piperidone and its synthesis method. Use of the thus-synthesized 3-piperidone compounds as potent neurokinin-1 (NK1) receptor antagonists is also provided.02-04-2016
546243000 At 2-position 4
20100286399PROCESS FOR THE PREPARATION OF AN N-ALKYL LACTAM WITH IMPROVED COLOUR QUALITY - A process for preparing an N-alkyllactam with improved color quality, wherein from 0.01 to 10% by weight of a C11-11-2010
20130204001PROCESS FOR PRODUCING COMPOUNDS COMPRISING NITRILE FUNCTIONS - The production of compounds comprising nitrile functions and of cyclic imide compounds is described. Further described, is the production of compounds comprising nitrile functions from compounds comprising carboxylic functions, optionally of natural and renewable origin, and from a mixture N of dinitriles comprising 2-methylglutaronitrile (MGN), 2-ethylsuccinonitrile (ESN) and adiponitrile (AdN).08-08-2013
20150051401PROCESS FOR PREPARING LACTAMS - The present invention relates to a method for preparing lactams using heterogeneous catalysis by hydrogenating at least one compound of the following formula (I), where A is a radical of the following formula (I′) or (II′): —CH(R02-19-2015
20150366851OSTEOPONTIN PRODUCTION INHIBITOR CONTAINING DICTYOPYRONE DERIVATIVE OR DIHYDRODICTYOPYRONE DERIVATIVE AS ACTIVE INGREDIENT - Disclosed herein is an osteopontin production inhibitor capable of preventing a disease resulting from increased production of osteopontin.12-24-2015

Patent applications in class Chalcogen bonded directly to ring carbon of the piperidine ring

Patent applications in all subclasses Chalcogen bonded directly to ring carbon of the piperidine ring

Website © 2025 Advameg, Inc.